A Multicenter Randomized Controlled Open-label Trial of Tenofovir Plus Entecavir Combination vs. Tenofovir Monotherapy in Chronic Hepatitis B Patients With Genotypic Resistance to Adefovir and Partial Virologic Response to Ongoing Treatment
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 24 Jun 2015 Planned End Date changed from 1 Jun 2014 to 1 Feb 2018 as reported by ClinicalTrials.gov.
- 09 Apr 2014 Preliminary results after 36 weeks of treatment presented at the 49th Annual Meeting of the European Association for the Study of the Liver.
- 15 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.